BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28932614)

  • 1. Acute Low-Dose Hydralazine-Induced Lupus Pneumonitis.
    Holman SK; Parris D; Meyers S; Ramirez J
    Case Rep Pulmonol; 2017; 2017():2650142. PubMed ID: 28932614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion.
    Elkholy KO; Akhtar H; Chakraborti A
    Cureus; 2020 Aug; 12(8):e9831. PubMed ID: 32953340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydralazine-Induced Isolated Lupus Nephritis.
    Khan N; Reichel R; Khurshid A; Tso K; Broussard J; Dass A
    Ochsner J; 2020; 20(2):187-192. PubMed ID: 32612474
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydralazine-associated vasculitis: Overlapping features of drug-induced lupus and vasculitis.
    Kumar B; Strouse J; Swee M; Lenert P; Suneja M
    Semin Arthritis Rheum; 2018 Oct; 48(2):283-287. PubMed ID: 29519741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics of Hydralazine-induced Lupus.
    Timlin H; Wu M; Crespo-Bosque M; Geetha D; Ingolia A; Haque U; Towns MC; Grader-Beck T
    Cureus; 2019 Jun; 11(6):e4996. PubMed ID: 31497427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An intriguing case of anemia and renal failure.
    Baradhi KM
    Proc (Bayl Univ Med Cent); 2019 Jan; 32(1):78-79. PubMed ID: 30956590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should the acetylator phenotype be determined when prescribing hydralazine for hypertension?
    Ramsay LE; Silas JH; Ollerenshaw JD; Tucker GT; Phillips FC; Freestone S
    Eur J Clin Pharmacol; 1984; 26(1):39-42. PubMed ID: 6714290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case for Biopsy: Injectable Naltrexone-Induced Acute Eosinophilic Pneumonia.
    Korpole PR; Al-Bacha S; Hamadeh S
    Cureus; 2020 Sep; 12(9):e10221. PubMed ID: 32913694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus Pneumonitis Therapy Masks Coronavirus (COVID-19).
    Soloway S; DePace NL; Soloway AM; Colombo J
    Case Rep Rheumatol; 2021; 2021():6645780. PubMed ID: 33927911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylator phenotype and the antihypertensive response to hydralazine.
    Jounela AJ; Pasanen M; Mattila MJ
    Acta Med Scand; 1975 Apr; 197(4):303-6. PubMed ID: 1136859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
    Dobre M; Wish J; Negrea L
    Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype.
    Russell GI; Bing RF; Jones JA; Thurston H; Swales JD
    Q J Med; 1987 Oct; 65(246):845-52. PubMed ID: 3329739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadralazine challenge in patients with previous hydralazine-induced lupus: a 6-month study.
    PĂ„lsson L; Weiner L; Englund G; Henning M
    Clin Pharmacol Ther; 1989 Aug; 46(2):177-81. PubMed ID: 2758727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic effects of hydralazine in hypertensive patients.
    Litwin A; Adams LE; Zimmer H; Hess EV
    Arthritis Rheum; 1981 Aug; 24(8):1074-8. PubMed ID: 6974554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New-onset systemic lupus erythematosus in a long-term hemodialysis patient with acute pleuritis and pneumonitis.
    Hiyamuta H; Yamada S; Yotsueda R; Hasegawa S; Nakano T; Taniguchi M; Tsukamoto H; Kitazono T; Tsuruya K
    CEN Case Rep; 2015 Nov; 4(2):139-144. PubMed ID: 28509090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sweet syndrome associated with hydralazine-induced lupus erythematosus.
    Cartee TV; Chen SC
    Cutis; 2012 Mar; 89(3):121-4. PubMed ID: 22530328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A One-Two Punch: Hydralazine-Induced Liver Injury in a Recovering Ischemic Hepatitis.
    Alansari A; Quiel L; Boma N
    Am J Ther; 2016; 23(4):e1094-5. PubMed ID: 25423497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydralazine, antinuclear antibodies, and the lupus syndrome.
    Mansilla-Tinoco R; Harland SJ; Ryan PJ; Bernstein RM; Dollery CT; Hughes GR; Bulpitt CJ; Morgan A; Jones JM
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):936-9. PubMed ID: 6802356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.